Medicina
Facultad
VU University Amsterdam
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de VU University Amsterdam (86)
2024
-
ESPEN practical short micronutrient guideline
Clinical Nutrition, Vol. 43, Núm. 3, pp. 825-857
-
High throughput LC-MS/MS method for steroid hormone analysis in rat liver and plasma – unraveling methodological challenges
Talanta, Vol. 266
-
Mapping gray and white matter volume abnormalities in early-onset psychosis: an ENIGMA multicenter voxel-based morphometry study
Molecular Psychiatry
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 13, pp. 6150-6160
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
Digital mental health: challenges and next steps
BMJ mental health, Vol. 26, Núm. 1
-
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure, Vol. 25, Núm. 4, pp. 469-477
-
Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research
Alzheimer's and Dementia, Vol. 19, Núm. 12, pp. 5817-5836
-
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission
British Journal of Haematology, Vol. 201, Núm. 6, pp. 1169-1178
-
Impact of stenosis resistance and coronary flow capacity on fractional flow reserve and instantaneous wave-free ratio discordance: a combined analysis of DEFINE-FLOW and IDEAL
Netherlands Heart Journal, Vol. 31, Núm. 11, pp. 434-443
-
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 14
-
Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma
Future Oncology, Vol. 19, Núm. 12, pp. 811-818
2022
-
A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function in Geriatric Patients
Drugs and Aging, Vol. 39, Núm. 11, pp. 863-874
-
Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure
Human Brain Mapping, Vol. 43, Núm. 1, pp. 37-55
-
Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer’s disease patients
PLoS ONE, Vol. 17, Núm. 4 April
-
ESPEN micronutrient guideline
Clinical Nutrition, Vol. 41, Núm. 6, pp. 1357-1424
-
Effect of disease related biases on the subjective assessment of social functioning in Alzheimer's disease and schizophrenia patients
Journal of Psychiatric Research, Vol. 145, pp. 302-308
-
Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial
European heart journal, Vol. 43, Núm. 38, pp. 3732-3745
-
Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs
Human Brain Mapping, Vol. 43, Núm. 1, pp. 300-328